Assenagon Asset Management S.A. Tg Therapeutics, Inc. Transaction History

Assenagon Asset Management S.A.

$65.1 Billion
Q3 2025

A detailed history of Assenagon Asset Management S.A. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 11,633 shares of TGTX stock, worth $408,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,633

Previous 6,172 88.48%

Holding current value

$408,550

Previous $222,000 89.19%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 07, 2025	BUY	$26.39 - $39.19 $144,115 - $214,016	5,461 Added 88.48%	11,633 $420,000
Q1 2025 Apr 15, 2025	SELL	$27.67 - $42.99 $2.68 Million - $4.17 Million	-96,908 Reduced 94.01%	6,172 $243,000
Q4 2024 Jan 14, 2025	SELL	$21.31 - $35.09 $1.43 Million - $2.36 Million	-67,154 Reduced 39.45%	103,080 $3.1 Million
Q3 2024 Oct 23, 2024	SELL	$17.21 - $25.28 $5.48 Million - $8.06 Million	-318,709 Reduced 65.18%	170,234 $3.98 Million
Q2 2024 Jul 18, 2024	BUY	$13.32 - $19.19 $6.51 Million - $9.38 Million	488,943 New	488,943 $8.7 Million
Q3 2023 Nov 06, 2023	BUY	$8.36 - $26.5 $1.22 Million - $3.86 Million	145,846 New	145,846 $1.22 Million
Q1 2023 Apr 18, 2023	BUY	$10.23 - $19.34 $2.36 Million - $4.46 Million	230,602 New	230,602 $3.47 Million
Q2 2022 Jul 27, 2022	BUY	$3.74 - $10.66 $6.86 Million - $19.6 Million	1,834,924 Added 722.33%	2,088,952 $8.88 Million
Q1 2022 Apr 25, 2022	BUY	$7.81 - $20.45 $721,245 - $1.89 Million	92,349 Added 57.12%	254,028 $2.42 Million
Q4 2021 Feb 01, 2022	BUY	$15.2 - $35.51 $2.46 Million - $5.74 Million	161,679 New	161,679 $3.07 Million
Q3 2021 Oct 19, 2021	SELL	$21.78 - $40.45 $3.33 Million - $6.18 Million	-152,823 Closed	0 $0
Q2 2021 Jul 15, 2021	SELL	$32.5 - $48.96 $111,280 - $167,639	-3,424 Reduced 2.19%	152,823 $5.93 Million
Q1 2021 Apr 26, 2021	BUY	$41.61 - $54.3 $6.5 Million - $8.48 Million	156,247 New	156,247 $7.53 Million
Q1 2019 Apr 26, 2019	SELL	$4.02 - $8.04 $629,933 - $1.26 Million	-156,700 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$3.44 - $5.76 $539,048 - $902,592	156,700 New	156,700 $642,000

Others Institutions Holding TGTX

# of Institutions

408

Shares Held

91.9M

Call Options Held

2.28M

Put Options Held

1.68M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $5.1B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Tg Therapeutics, Inc. Transaction History